OncoMed Pharmaceuticals Inc 4
4 · OncoMed Pharmaceuticals Inc · Filed Apr 5, 2017
Insider Transaction Report
Form 4
Gurney Austin
See Remarks
Transactions
- Sale
Common Stock
2017-04-04$8.87/sh−43$381→ 49,012 total - Sale
Common Stock
2017-04-04$9.06/sh−5,711$51,731→ 43,301 total
Footnotes (3)
- [F1]Pursuant to a sell-to-cover election made by the Reporting Person at the time of the initial grant of the restricted stock unit award, the shares were sold upon the vesting of restricted stock units solely to cover applicable withholding taxes.
- [F2]Includes 12,500 restricted stock units ("RSUs"). The reporting person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof.
- [F3]Includes 2,000 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2017.